Key facts
- This page summarizes Melissa Tosca's Form 4 filing for KIORA PHARMACEUTICALS INC (KPRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2026, 16:47.
Melissa Tosca - 01 Jul 2026 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2026, 16:47:12 UTC
- Prior SEC filing
- 02 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa Tosca
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Melissa Tosca filed Form 4 for KIORA PHARMACEUTICALS INC (KPRX) on 02 Jul 2026.
Change
- Previous filing in this sequence was filed on 02 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001947184
Primary reporting owner
Tosca Melissa
- Relationship
- CFO
- Address
- C/O KIORA PHARMACEUTICALS, INC., 169 SAXONY RD., SUITE 212, ENCINITAS
- Signature
- /s/ Melissa Tosca
- Signature date
- 02 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KPRX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -911
- Change %
- -3.4%
- Price
- $2.66*
- Shares after
- 26,064
- Date
- 01 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Net Share settlement, shares withheld for employee tax obligation upon vesting of restricted stock.